Summary
This 8-K filing by Abbott Laboratories (ABT), dated August 13, 2002, primarily serves to present sworn statements from its Chief Executive Officer and Chief Financial Officer. These statements, dated August 13, 2002, are provided pursuant to Securities and Exchange Commission Order No. 4-460. The filing itself does not contain new financial data, operational updates, or significant business developments beyond the submission of these official certifications. Investors should note that the core of this report lies in these sworn statements, which are likely a response to regulatory requirements or inquiries related to the accounting and financial reporting practices of Abbott Laboratories at that time. While the specific content of the sworn statements is not detailed in the provided excerpt, their submission indicates a focus on ensuring the accuracy and integrity of the company's disclosed financial information.
Key Highlights
- 1Filing Date: August 13, 2002.
- 2Company: Abbott Laboratories (ABT).
- 3Report Type: Form 8-K (Current Report).
- 4Key Items: Submission of sworn statements from CEO and CFO (Exhibits 99.1 and 99.2).
- 5Regulatory Basis: Statements provided pursuant to SEC Order No. 4-460.
- 6Purpose: Compliance with regulatory directives concerning financial reporting.
- 7Nature of Report: Primarily procedural, presenting official certifications rather than new business disclosures.